Dear Readers,
Welcome to our weekly company result update note. We understand the importance of staying up-to-date with the latest financial developments of the companies you have invested in. That’s why we are committed to providing you with short and insightful information about the earnings and performance of the companies in our coverage.
In addition to the weekly company result update, after the end of the earnings season, we will also be sending you a quarterly sector result review. This will give you a broader understanding of how these sectors are performing and help you make informed decisions about your investments.
SBI
Q4FY23 | % Change YoY | Comments | |
Advances | 31,99,269 | 17.0% | |
Deposits | 44,23,777 | 9.2% | |
Net Interest Income (NII) | 40,392.5 | 29.5% | NIM at 3.84% |
Gross Non-Performing Asset (GNPA) | 2.78% | -118 bps | |
Profit after tax (PAT) | 16,694.5 | 83.2% |
Results were good on account of GNPA improvement.
Cipla
|
Q4FY23 |
YOY(%) |
Comment |
Revenue Net | 5,739 | 9.1 | Domestic formulation sales grew by 3.5% YoY |
EBITDA | 1,174 | 56.6 | |
EBITDA Margin | 20.5% | 620 | |
PAT | 704 | 64.4 |
Adjusted for COVID, growth was 14% YoY led by momentum across a portfolio of the One-India business. US sales came in at $204mn. International markets grew by 7% YoY, while SAGA reported a 13% decline. API saw a decline of 3% YoY.
At Par Result.
ITC
Q4FY23 | YoY(%) | Comments | |
Revenue Net | 16,150 | 5.5 | FMCG revenue grew by 19.4% to 4,945 Cr |
EBITDA | 6,209 | 18.9 | |
EBITDA Margin | 38.45% | 626bps | |
PAT | 5087 | 21.4 |
Good Result on account of increase in revenue and improvement in Margin across all segments.
Advanced Enzyme
|
Q4FY23 |
YOY (%) |
Comment |
Revenue | 139 | 5.3 | The Human Nutrition segment, which contributes ~63% to overall revenue and is even higher in terms of profit, continued to witness weakness on account of recessionary trends in the USA and inventory pile-up at the customers’ end. Ex-Human Nutrition, the portfolio grew by 13% YoY in 4QFY23. |
EBITDA | 44 | 9.5 | |
EBITDA Margin | 31.8% | 122bps | |
PAT | 32 | 27 |
At Par Result, US business to drive forward margins.
Amber Enterprises
|
Q4FY23 |
YOY (%) |
Comment |
Revenue | 3003 | 55 | Led by an uptick in demand for RAC & components coupled with new customer additions. |
EBITDA | 204 | 62.4 | |
EBITDA Margin | 6.8% | 31bps | Gross margin remained flat YoY mainly due to a change in product mix. However, better operating leverage resulted in an
EBITDA margin improvement |
PAT | 108 | 82.3 |
Good Result driven by margin improvement.
Kajaria Ceramics
|
Q4FY23 |
YOY (%) |
Comment |
Revenue ( Consolidated) | 1,205 | 9 | |
EBITDA | 176 | 6 | |
EBITDA Margin | 14.60% | -46bps | Improvement in EBITDA margin of 240bps on QOQ basis on account of decline in gas prices and cost optimization initiative. |
PAT | 108 | 13 |
The decent result on account of easing in input costs.
Bank of Baroda
Q4FY23 | % Change YoY | Comments | |
Advances | 9,69,548 | 18.5% | International advances grew by 29.9% to 173,988 Cr |
Deposits | 12,03,688 | 15.1% | |
Net Interest Income (NII) | 11,525 | 33.8% | NIM at 3.53% |
Gross Non-Performing Asset (GNPA) | 3.79% | -282 bps | |
Profit after tax (PAT) | 4,775 | 168.4% |
Results were good, with solid fundamentals on all metrics.
Bharti Airtel
Q4FY23 | % Change YoY | Comments | |
Revenue | 36,009 | 14.3% | ARPU at 193, Enterprise segment grew by 14.5% to 4,785 Cr, 7.4 Mn 4G subscribers added |
EBITDA | 18,806 | 16.6% | EBITDA margin at 52.2% |
PAT | 3,005 | 49.7% |
Stable results driven by growth in subscribers & enterprise segment.
Quess Corp Limited
Rs (Cr) |
Q4FY23 |
YoY(%) |
Comment |
Revenue ( Consolidated) | 4,440 | 17 | Driven by WFM (up 16%), OAM (up 19%), and GTS (up 20%). |
EBITDA | 152 | -18 | |
EBITDA Margin | 3.42% | -146bps | Due to investments in Product Led Business. |
PAT | 30 | -61 |
At Par Result.
Container Corporation
Q4FY23 | % Change YoY | Comments | |
Revenue | 2,184 | 6.2% | |
EBITDA | 451 | 8.1% | EBITDA margin at 20.6% |
PAT | 279 | 7.1% |
Subpar results on account of muted EXIM volumes.
Check, 10-Year X-ray Now!
CreditAccess Grameen
Q4FY23 | % Change YoY | Comments | |
Advances | 21,031 | 26.7% | |
Net Interest Income (NII) | 690 | 34.2% | NIM at 12.2% |
Gross Non-Performing Asset (GNPA) | 1.21% | -170 bps | |
Profit after tax (PAT) | 296 | 86% |
A solid set of results with improving metrics on all parameters.
Best Stocks From:
All Weather Alpha Case Screener Alpha Cases Business Houses Group
Need help on Investing? And more….Puchho Befikar
Why MoneyWorks4me | Call: 020 6725 8333 | Ebook | WhatsApp: 9860359463
*Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
*Disclaimer: The securities quoted are for illustration only and are not recommendatory